Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - TOTAL RECEIVABLES
Total Receivables ENTA - Enanta Pharmaceuticals, Inc.
6.65 M
LAST VALUE
-63.19%
2 YEAR CAGR
-33.55%
5 YEAR CAGR
3.99%
10 YEAR CAGR